# A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

> **NCT06667453** · PHASE2 · RECRUITING · sponsor: **PepGen Inc** · enrollment: 24 (estimated)

## Conditions studied

- Myotonic Dystrophy 1

## Interventions

- **DRUG:** PGN-EDODM1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06667453
- **Lead sponsor:** PepGen Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06667453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06667453, "A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06667453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*